48 filings
Page 2 of 3
8-K/A
9b1mxk lymypf
22 Sep 22
Submission of Matters to a Vote of Security Holders
7:41am
8-K
ij5bi404wo
4 Aug 22
C4 Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights
8:15am
8-K
hgiz9k0ck5ns8z6
2 Aug 22
C4 Therapeutics Appoints Experienced Clinical Development Leaders Laura Bessen, M.D. and Donna Grogan, M.D. to Board of Directors
8:33am
8-K
m8nthv7fn9
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
r0qucr
17 Jun 22
Departure of Directors or Certain Officers
4:05pm
8-K
7ybg pwmrg93t3m272
16 May 22
Other Events
4:57pm
8-K
fzyd1v k0
5 May 22
C4 Therapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights
8:06am
8-K
tg4eazjn8le5vk5v
8 Apr 22
C4 Therapeutics Presents Clinical Data from Cohort A of the Ongoing Phase 1/2 Clinical Trial of CFT7455, a Novel IKZF1/3 Degrader
1:21pm
8-K
70d67kkba
16 Mar 22
C4 Therapeutics Appoints Utpal Koppikar to Board of Directors
4:15pm
8-K
thnv7l
24 Feb 22
C4 Therapeutics Reports Full Year 2021 Financial Results and Recent Business Highlights
7:30am
8-K/A
v8eihqhegyifbxm0 b8
21 Jan 22
Financial Statements and Exhibits
4:12pm
8-K
ia87u0
10 Jan 22
C4 Therapeutics Announces 2022 Key Milestones to Advance Targeted Protein Degradation Portfolio
7:45am
8-K
jwto34ki24
30 Nov 21
Entry into a Material Definitive Agreement
4:18pm
8-K
b4ts3rzp
10 Nov 21
C4 Therapeutics Reports Recent Business Highlights and Third Quarter 2021 Financial Results
4:12pm
8-K
kk3waurltksewkyysbb
11 Aug 21
C4 Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
4:07pm
8-K
mokwf
21 Jun 21
Submission of Matters to a Vote of Security Holders
4:26pm
8-K
005mz uyoroojm07
14 Jun 21
Other Events
4:17pm
8-K
g0ysov t0
7 Jun 21
C4 Therapeutics Presents Pre-clinical Data on CFT8919, A Selective Degrader of EGFR L858R, at Keystone Symposium on Targeted Protein Degradation
7:25am
8-K
hwa2hg7n0mhy
26 May 21
Regulation FD Disclosure
4:28pm
8-K
3j5z bam55b1
20 May 21
C4 Therapeutics Appoints Lauren White as Chief Financial Officer
4:22pm